SupplySide Global 2025: Wecare Probiotics’ clinical insights for Akkermansia-based health solutions
19 Nov 2025 | Wecare Probiotics
At the trade show, we caught up with Dr. George Zhou, director of applied technology at Wecare Probiotics, to discuss the company’s latest breakthroughs in Akkermansia-based metabolic health solutions. Zhou explained how its proprietary strains support gut barrier integrity, weight management, and overall metabolic resilience — addressing one of the fastest-growing categories in microbiome science. We also discussed formulation advances, clinical validation, and how Wecare Probiotics is helping brands bring next-generation Akkermansia products to market with greater stability, efficacy, and consumer impact.
